Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CNY 119.32 million compared to CNY 99.76 million a year ago. Net loss was CNY 6.04 million compared to CNY 8.38 million a year ago. Basic loss per share from continuing operations was CNY 0.00319 compared to CNY 0.00443 a year ago.
For the nine months, sales was CNY 305.23 million compared to CNY 304.97 million a year ago. Net loss was CNY 17.29 million compared to CNY 21.63 million a year ago. Basic loss per share from continuing operations was CNY 0.00913 compared to CNY 0.01142 a year ago.